drugset / Trial / NCT00295555

Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy

NCT00295555

Phase 4 Completed 98 enrolled Yokohama City University Medical Center
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Few studies have reported the effect of alpha1-adrenergic antagonists on 24-h blood pressure and regulation of sympathetic nervous activity in hypertensive patients with diabetic nephropathy. Using ambulatory blood pressure monitoring devices equipped with spectral analysis of heart rate variability, we assess the effects of doxazosin on blood pressure in diabetic nephropathy patients and compare the results with those in patients with essential hypertension, patients with diabetes mellitus and patients with chronic nephropathy.

Timeline

Start
2004-01
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxazosin Small molecule 2 mg
Subject Doxazosin Small molecule 8 mg